Related Experiment Video
Updated: Feb 22, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
High mobility group box 1 in diabetic nephropathy.
Haitao Shi1, Yingqi Che2, Lin Bai1
1Department of Nephrology, Longnan Hospital, Daqing, Heilongjiang 163000, P.R. China.
Diabetic nephropathy (DN) detection is often delayed, leading to significant kidney damage. High mobility group box 1 (HMGB1) shows promise as an early biomarker for managing DN, potentially improving patient outcomes.
Area of Science:
- Nephrology
- Endocrinology
- Biochemistry
Background:
- Type 2 diabetes (T2D) is a complex condition influenced by genetics and environment.
- Diabetic nephropathy (DN) is characterized by albuminuria, but its detection is often delayed, resulting in extensive kidney damage.
- Current biomarkers like microalbuminuria can yield false negatives, hindering timely DN management.
Purpose of the Study:
- To review the current status and potential of High Mobility Group Box 1 (HMGB1) as a biomarker in diabetic nephropathy.
- To highlight the limitations of existing DN detection methods.
- To explore HMGB1's role in early DN management and improved patient outcomes.
Main Methods:
- Literature review of studies investigating HMGB1 in the context of diabetic nephropathy.
- Analysis of current diagnostic markers for DN and their shortcomings.
- Exploration of emerging research on HMGB1 as a potential biomarker.
Main Results:
- HMGB1 is an emerging molecule with potential applications in DN management.
- Delayed detection of DN via traditional markers like albuminuria leads to irreversible kidney damage.
- HMGB1 may offer a more sensitive and earlier indicator for DN compared to current methods.
Conclusions:
- HMGB1 presents a promising avenue for early detection and management of diabetic nephropathy.
- Further research into HMGB1's role could lead to improved therapeutic strategies for DN patients.
- Addressing the limitations of current biomarkers is crucial for effective DN intervention.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease I: Introduction

